AAAAAA

   
Results: 1-25 | 26-29
Results: 1-25/29
PROSPECTIVELY RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT CHEMOTHERAPYIN PATIENTS WITH HIGH-RISK COLON-CANCER
Authors: OCONNELL MJ LAURIE JA KAHN M FITZGIBBONS RJ ERLICHMAN C SHEPHERD L MOERTEL CG KOCHA WI PAZDUR R WIEAND HS RUBIN J VUKOV AM DONOHUE JH KROOK JE FIGUEREDO A
Citation: Mj. Oconnell et al., PROSPECTIVELY RANDOMIZED TRIAL OF POSTOPERATIVE ADJUVANT CHEMOTHERAPYIN PATIENTS WITH HIGH-RISK COLON-CANCER, Journal of clinical oncology, 16(1), 1998, pp. 295-300
CONTROLLED TRIAL OF FLUOROURACIL AND LOW-DOSE LEUCOVORIN GIVEN FOR 6 MONTHS AS POSTOPERATIVE ADJUVANT THERAPY FOR COLON-CANCER
Authors: OCONNELL MJ MAILLIARD JA KAHN MJ MACDONALD JS HALLER DG MAYER RJ WIEAND HS
Citation: Mj. Oconnell et al., CONTROLLED TRIAL OF FLUOROURACIL AND LOW-DOSE LEUCOVORIN GIVEN FOR 6 MONTHS AS POSTOPERATIVE ADJUVANT THERAPY FOR COLON-CANCER, Journal of clinical oncology, 15(1), 1997, pp. 246-250
GRANULOCYTE-COLONY-STIMULATING FACTOR IN SEVERE CHEMOTHERAPY-INDUCED AFEBRILE NEUTROPENIA
Authors: HARTMANN LC TSCHETTIER LK HABERMANN TM EBBERT LP JOHNSON PS MAILLIARD JA LEVITT R SUMAN VJ WITZIG TE WIEAND HS MILLER LL MOERTEL CG
Citation: Lc. Hartmann et al., GRANULOCYTE-COLONY-STIMULATING FACTOR IN SEVERE CHEMOTHERAPY-INDUCED AFEBRILE NEUTROPENIA, The New England journal of medicine, 336(25), 1997, pp. 1776-1780
A CLINICAL-TRIAL TO EVALUATE THE WORTH OF PREOPERATIVE MULTIMODALITY THERAPY IN PATIENTS WITH OPERABLE CARCINOMA OF THE RECTUM - A PROGRESSREPORT OF NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL R-03
Authors: HYAMS DM MAMOUNAS EP PETRELLI N ROCKETTE H JONES J WIEAND HS DEUTSCH M WICKERHAM DL FISHER B WOLMARK N
Citation: Dm. Hyams et al., A CLINICAL-TRIAL TO EVALUATE THE WORTH OF PREOPERATIVE MULTIMODALITY THERAPY IN PATIENTS WITH OPERABLE CARCINOMA OF THE RECTUM - A PROGRESSREPORT OF NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT PROTOCOL R-03, Diseases of the colon & rectum, 40(2), 1997, pp. 131-139
A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER
Authors: GELBER RD GOLDHIRSCH A COLE BF WIEAND HS SCHROEDER G KROOK JE
Citation: Rd. Gelber et al., A QUALITY-ADJUSTED TIME WITHOUT SYMPTOMS OR TOXICITY (Q-TWIST) ANALYSIS OF ADJUVANT RADIATION-THERAPY AND CHEMOTHERAPY FOR RESECTABLE RECTAL-CANCER, Journal of the National Cancer Institute, 88(15), 1996, pp. 1039-1045
DNA INDEX BY FLOW CYTOMETRIC ANALYSIS - AN ADDITIONAL PROGNOSTIC FACTOR IN ADVANCED OVARIAN-CARCINOMA WITHOUT RESIDUAL DISEASE AFTER PRIMARY OPERATION
Authors: ZANETTA G KEENEY GL CHA SS WIEAND HS KATZMANN JA PODRATZ KC
Citation: G. Zanetta et al., DNA INDEX BY FLOW CYTOMETRIC ANALYSIS - AN ADDITIONAL PROGNOSTIC FACTOR IN ADVANCED OVARIAN-CARCINOMA WITHOUT RESIDUAL DISEASE AFTER PRIMARY OPERATION, Gynecologic oncology, 62(2), 1996, pp. 208-212
STOOL SCREENING COMPLIANCE AMONG COLORECTAL-CANCER RELATIVES - GENDERAND AGE EFFECTS
Authors: SWAROOP VS AHLQUIST DA WIEAND HS MCGILL DB CHA SS LOPRINZI CL OCONNELL MJ MAILLIARD JA
Citation: Vs. Swaroop et al., STOOL SCREENING COMPLIANCE AMONG COLORECTAL-CANCER RELATIVES - GENDERAND AGE EFFECTS, Gastroenterology, 110(4), 1996, pp. 587-587
WOUND RECURRENCE FOLLOWING CONVENTIONAL TREATMENT OF COLORECTAL-CANCER - A RARE BUT PERHAPS UNDERESTIMATED PROBLEM
Authors: REILLY WT NELSON H SCHROEDER G WIEAND HS BOLTON J OCONNELL MJ
Citation: Wt. Reilly et al., WOUND RECURRENCE FOLLOWING CONVENTIONAL TREATMENT OF COLORECTAL-CANCER - A RARE BUT PERHAPS UNDERESTIMATED PROBLEM, Diseases of the colon & rectum, 39(2), 1996, pp. 200-207
COMPARISON OF ESTROGEN-RECEPTOR DETERMINATIONS BY A BIOCHEMICAL LIGAND-BINDING ASSAY AND IMMUNOHISTOCHEMICAL STAINING WITH MONOCLONAL-ANTIBODY ER1D5 IN FEMALES WITH LYMPH-NODE POSITIVE BREAST-CARCINOMA ENTEREDON 2 PROSPECTIVE CLINICAL-TRIALS
Authors: ALBERTS SR INGLE JN ROCHE PR CHA SS WOLD LE FARR GH KROOK JE WIEAND HS
Citation: Sr. Alberts et al., COMPARISON OF ESTROGEN-RECEPTOR DETERMINATIONS BY A BIOCHEMICAL LIGAND-BINDING ASSAY AND IMMUNOHISTOCHEMICAL STAINING WITH MONOCLONAL-ANTIBODY ER1D5 IN FEMALES WITH LYMPH-NODE POSITIVE BREAST-CARCINOMA ENTEREDON 2 PROSPECTIVE CLINICAL-TRIALS, Cancer, 78(4), 1996, pp. 764-772
A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA - REPLY
Authors: GOLDBERG RM WIEAND HS KROOK JE SCHUTT AJ VEEDER MH MAILLAIRD JA DALTON RJ
Citation: Rm. Goldberg et al., A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA - REPLY, Cancer, 77(9), 1996, pp. 1956-1957
PROGNOSTIC FACTORS IN ELDERLY WOMEN WITH METASTATIC BREAST-CANCER TREATED WITH TAMOXIFEN - AN ANALYSIS OF PATIENTS ENTERED ON 4 PROSPECTIVECLINICAL-TRIALS
Authors: DHODAPKAR MV INGLE JN CHA SS MAILLIARD JA WIEAND HS
Citation: Mv. Dhodapkar et al., PROGNOSTIC FACTORS IN ELDERLY WOMEN WITH METASTATIC BREAST-CANCER TREATED WITH TAMOXIFEN - AN ANALYSIS OF PATIENTS ENTERED ON 4 PROSPECTIVECLINICAL-TRIALS, Cancer, 77(4), 1996, pp. 683-690
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF G-CSF FOR FEBRILE-NEUTROPENIC PATIENTS
Authors: HABERMANN TM HARTMANN LC TSCHETTER LK WIEAND HS EBBERT LP MAILLIARD JA LEVITT R WITZIG TE SUMAN V
Citation: Tm. Habermann et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF G-CSF FOR FEBRILE-NEUTROPENIC PATIENTS, Blood, 88(10), 1996, pp. 1375-1375
FLOW-CYTOMETRIC ANALYSIS OF DEOXYRIBONUCLEIC-ACID CONTENT IN ADVANCEDOVARIAN-CARCINOMA - ITS IMPORTANCE IN LONG-TERM SURVIVAL
Authors: ZANETTA G KEENEY GL CHA SS FARR GH KATZMANN JA WIEAND HS EDMONSON JH PODRATZ KC
Citation: G. Zanetta et al., FLOW-CYTOMETRIC ANALYSIS OF DEOXYRIBONUCLEIC-ACID CONTENT IN ADVANCEDOVARIAN-CARCINOMA - ITS IMPORTANCE IN LONG-TERM SURVIVAL, American journal of obstetrics and gynecology, 175(5), 1996, pp. 1217-1225
CONTROLLED CLINICAL-TRIAL OF INTERFERON-GAMMA AS POSTOPERATIVE SURGICAL ADJUVANT THERAPY FOR COLON-CANCER
Authors: WIESENFELD M OCONNELL MJ WIEAND HS GONCHOROFF NJ DONOHUE JH FITZGIBBONS RJ KROOK JE MAILLIARD JA GERSTNER JB PAZDUR R
Citation: M. Wiesenfeld et al., CONTROLLED CLINICAL-TRIAL OF INTERFERON-GAMMA AS POSTOPERATIVE SURGICAL ADJUVANT THERAPY FOR COLON-CANCER, Journal of clinical oncology, 13(9), 1995, pp. 2324-2329
PERIOPERATIVE BLOOD-TRANSFUSIONS DO NOT AFFECT DISEASE RECURRENCE OF PATIENTS UNDERGOING CURATIVE RESECTION OF COLORECTAL-CARCINOMA - A MAYO NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY/
Authors: DONOHUE JH WILLIAMS S CHA S WINDSCHITL HE WITZIG TE NELSON H FITZGIBBONS RJ WIEAND HS MOERTEL CG
Citation: Jh. Donohue et al., PERIOPERATIVE BLOOD-TRANSFUSIONS DO NOT AFFECT DISEASE RECURRENCE OF PATIENTS UNDERGOING CURATIVE RESECTION OF COLORECTAL-CARCINOMA - A MAYO NORTH CENTRAL CANCER-TREATMENT GROUP-STUDY/, Journal of clinical oncology, 13(7), 1995, pp. 1671-1678
EVALUATION OF IFOSFAMIDE PLUS MESNA AS FIRST-LINE CHEMOTHERAPY IN WOMEN WITH METASTATIC BREAST-CANCER
Authors: INGLE JN KROOK JE MAILLIARD JA HARTMANN LC WIEAND HS
Citation: Jn. Ingle et al., EVALUATION OF IFOSFAMIDE PLUS MESNA AS FIRST-LINE CHEMOTHERAPY IN WOMEN WITH METASTATIC BREAST-CANCER, American journal of clinical oncology, 18(6), 1995, pp. 498-501
PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA
Authors: LONG HJ CROSS WG WIEAND HS WEBB MJ MAILLIARD JA KUGLER JW TSCHETTER LK KARDINAL CG EBBERT LP RAYSON S
Citation: Hj. Long et al., PHASE-II TRIAL OF METHOTREXATE, VINBLASTINE, DOXORUBICIN, AND CISPLATIN IN ADVANCED RECURRENT CARCINOMA OF THE UTERINE CERVIX AND VAGINA, Gynecologic oncology, 57(2), 1995, pp. 235-239
A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA
Authors: GOLDBERG RM MOERTEL CG WIEAND HS KROOK JE SCHUTT AJ VEEDER MH MAILLIARD JA DALTON RJ
Citation: Rm. Goldberg et al., A PHASE-III EVALUATION OF A SOMATOSTATIN ANALOG (OCTREOTIDE) IN THE TREATMENT OF PATIENTS WITH ASYMPTOMATIC ADVANCED COLON-CARCINOMA, Cancer, 76(6), 1995, pp. 961-966
C-ERBB-2 AND P53 EXPRESSION IN FALLOPIAN-TUBE CARCINOMA
Authors: LACY MQ HARTMANN LC KEENEY GL CHA SC WIEAND HS PODRATZ KC ROCHE PC
Citation: Mq. Lacy et al., C-ERBB-2 AND P53 EXPRESSION IN FALLOPIAN-TUBE CARCINOMA, Cancer, 75(12), 1995, pp. 2891-2896
P53 GENE-EXPRESSION IN NODE-POSITIVE BREAST-CANCER - RELATIONSHIP TO DNA-PLOIDY AND PROGNOSIS
Authors: CUNNINGHAM JM INGLE JN JUNG SH CHA SS WOLD LE FARR G WITZIG TE KROOK JE WIEAND HS KOVACH JS
Citation: Jm. Cunningham et al., P53 GENE-EXPRESSION IN NODE-POSITIVE BREAST-CANCER - RELATIONSHIP TO DNA-PLOIDY AND PROGNOSIS, Journal of the National Cancer Institute, 86(24), 1994, pp. 1871-1873
ADVANCED COLORECTAL ADENOCARCINOMA - TREATMENT WITH AMONAFIDE
Authors: MARSCHKE RF WIEAND HS OCONNELL MJ SCHUTT AJ BURCH PA KOVACH JS
Citation: Rf. Marschke et al., ADVANCED COLORECTAL ADENOCARCINOMA - TREATMENT WITH AMONAFIDE, Journal of the National Cancer Institute, 86(12), 1994, pp. 944-945
BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION
Authors: GRIEVE AP POCOCK SJ ABRAMS K ASHBY D HEALY MJR JENNISON C LEWIS JA LINDLEY DV MACHIN D NEWMAN GB BATHER JA BAILEY RA EVANS SJW KEIDING N MATTHEWS JNS GORE SM SENN S HERSON J TURNBULL BW ALTMAN DG ARMITAGE P ATKINSON AC BERRY DA BUYSE ME CARLIN BP DEMETS DL DEMPSTER AP DUNSTAN FDJ ELLENBERG SS FAYERS P GAIL MH GEORGE SL GREENHOUSE JB WASSERMAN LA HARRELL FE JOSEPH L SHAPIRO SH KADANE JB LEHMANN HP MARUBINI E MARIANI L PATER JL PETTIT LI YOUNG KDS ROSNER GL WHITEHEAD J WIEAND HS
Citation: Ap. Grieve et al., BAYESIAN APPROACHES TO RANDOMIZED TRIALS - DISCUSSION, Journal of the Royal Statistical Society. Series A. Statistics in society, 157, 1994, pp. 387-416
PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETEDQUESTIONNAIRES
Authors: LOPRINZI CL LAURIE JA WIEAND HS KROOK JE NOVOTNY PJ KUGLER JW BARTEL J LAW M BATEMAN M KLATT NE DOSE AM ETZELL PS NELIMARK RA MAILLIARD JA MOERTEL CG
Citation: Cl. Loprinzi et al., PROSPECTIVE EVALUATION OF PROGNOSTIC VARIABLES FROM PATIENT-COMPLETEDQUESTIONNAIRES, Journal of clinical oncology, 12(3), 1994, pp. 601-607
CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER
Authors: CULLINAN SA MOERTEL CG WIEAND HS OCONNELL MJ POON MA KROOK JE MAILLIARD JA TSCHETTER LK
Citation: Sa. Cullinan et al., CONTROLLED EVALUATION OF 3 DRUG-COMBINATION REGIMENS VERSUS FLUOROURACIL ALONE FOR THE THERAPY OF ADVANCED GASTRIC-CANCER, Journal of clinical oncology, 12(2), 1994, pp. 412-416
RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER
Authors: BUROKER TR OCONNELL MJ WIEAND HS KROOK JE GERSTNER JB MAILLIARD JA SCHAEFER PL LEVITT R KARDINAL CG GESME DH
Citation: Tr. Buroker et al., RANDOMIZED COMPARISON OF 2 SCHEDULES OF FLUOROURACIL AND LEUCOVORIN IN THE TREATMENT OF ADVANCED COLORECTAL-CANCER, Journal of clinical oncology, 12(1), 1994, pp. 14-20
Risultati: 1-25 | 26-29